Cargando…

Second COVID-19 infection in a patient with multiple myeloma in Brazil – reinfection or reactivation?

Detalles Bibliográficos
Autores principales:	Bellesso, Marcelo, Bruniera, Felipe Ribeiro, Trunkel, Ariel Testasicca, Nicodemo, Izabel Pernambuco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837121/ https://www.ncbi.nlm.nih.gov/pubmed/33423984 http://dx.doi.org/10.1016/j.htct.2020.12.002

Ejemplares similares

SEVERE COVID19 IN PATIENTS WITH CANCER: ANALYSIS OF MORTALITY, ADMISSION TO INTENSIVE CARE UNIT AND INVASIVE VENTILATION
por: Bellesso, M., et al.
Publicado: (2020)

Febrile neutropenia studies in Brazil - treatment and cost management based on analyses of cases
por: Bellesso, Marcelo
Publicado: (2013)

REINFECTION (SECOND ATTACK) IN EXPERIMENTAL POLIOMYELITIS
por: Flexner, Simon
Publicado: (1937)

Reinfection and reactivation of SARS-CoV-2
por: Dowran, Razieh, et al.
Publicado: (2022)

Reinfection, reactivation or delayed complication of the initial SARS-CoV-2 infection()
por: González-Iglesias, Ignacio, et al.
Publicado: (2021)

Risk of reactivation or reinfection of novel coronavirus (COVID-19)
por: Alizargar, Javad
Publicado: (2020)

HEPATITIS B VACCINATION COVERAGE AND POSTVACCINATION SEROLOGIC TESTING AMONG MEDICAL STUDENTS AT A PUBLIC UNIVERSITY IN BRAZIL
por: de Souza, Eduardo Pernambuco, et al.
Publicado: (2014)

Multiple drugs: COVID-19 reinfection, COVID-19 reactivation and differentiation syndrome: case report
Publicado: (2021)

Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil
por: Fintelman-Rodrigues, Natalia, et al.
Publicado: (2021)

Characterisation of Omicron Variant during COVID-19 Pandemic and the Impact of Vaccination, Transmission Rate, Mortality, and Reinfection in South Africa, Germany, and Brazil
por: Ribeiro Xavier, Carolina, et al.
Publicado: (2022)

COVID‐19 reinfection or reactivation in a renal transplant patient
por: Abolghasemi, Sara, et al.
Publicado: (2021)

Reinfections with SARS-CoV-2 or second COVID-19 episodes?
por: Cabrera-Gaytán, David Alejandro, et al.
Publicado: (2021)

Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020
por: Amorim, Mariene R., et al.
Publicado: (2021)

SARS-CoV-2 reinfection: report of two cases in Southeast Brazil
por: Yu, Ana Lucia Frugis, et al.
Publicado: (2021)

Genomic evidence of SARS-CoV-2 reinfection cases in southern Brazil
por: Varela, Ana Paula Muterle, et al.
Publicado: (2023)

Molecular genotyping to differentiate endogenous reactivation and exogenous reinfection of recurrent tuberculosis
por: Suzana, Shirly, et al.
Publicado: (2018)

COVID-19: Is Reinfection a Threat or Not?
por: PORRAS VILLAMIL, Julián Felipe, et al.
Publicado: (2020)

Larynx cancer mortality in the State of Pernambuco-Brazil-2000-2004
por: Pernambuco, Leandro de Araújo, et al.
Publicado: (2015)

HTLV infection in Brazil’s second-largest indigenous reserve
por: Amianti, Carolina, et al.
Publicado: (2022)

Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma
por: Tsukune, Yutaka, et al.
Publicado: (2019)

Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil
por: Fonseca, Vagner, et al.
Publicado: (2021)

COVID-19 reinfection: prolonged shedding or true reinfection?
por: Falahi, S., et al.
Publicado: (2020)

Multiple exposures, reinfection and risk of progression to active tuberculosis
por: Ackley, Sarah F., et al.
Publicado: (2019)

Multiple myeloma: family history and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients
por: Avivi, Irit, et al.
Publicado: (2023)

Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries
por: Chen, Tianhui, et al.
Publicado: (2016)

Reinfection cases by closely related SARS-CoV-2 lineages in Southern Brazil
por: Gularte, Juliana Schons, et al.
Publicado: (2021)

Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil
por: Prete, Carlos A., et al.
Publicado: (2022)

Reinfection or Reactivation of Coronavirus-19 in Patients with Hematologic Malignancies: Case Report Series
por: Kapoor, Rajan, et al.
Publicado: (2021)

Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report
por: Centrone, Renato, et al.
Publicado: (2020)

COVID-19 infection, reinfection, and the transition to endemicity
por: Cohen, Cheryl, et al.
Publicado: (2023)

Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen?
por: Crusoe, Edvan de Queiroz, et al.
Publicado: (2016)

Multiple drugs: Covid-19 reinfection: 2 case reports
Publicado: (2021)

Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma
por: Bhutani, Divaya, et al.
Publicado: (2017)

Second Primary Malignancy Risk in Multiple Myeloma from 1975 to 2018
por: Wang, Jing, et al.
Publicado: (2022)

Causes of Death among People Living with AIDS in the Pre- and Post-HAART Eras in the City of São Paulo, Brazil
por: Domingues, Carmen-Silvia Bruniera, et al.
Publicado: (2014)

Multiple SARS-CoV-2 Reinfections: A Case Series of Thrice-Infected Individuals
por: Swift, Melanie D., et al.
Publicado: (2022)

Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review
por: Tang, Xiujuan, et al.
Publicado: (2021)

Laryngeal Involvement of Multiple Myeloma
por: Grobman, Ariel B., et al.
Publicado: (2012)

USEFULNESS OF kDNA PCR IN THE DIAGNOSIS OF VISCERAL LEISHMANIASIS REACTIVATION IN CO-INFECTED PATIENTS
por: Nicodemo, Antonio Carlos, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r6t2kaesf2vrm1iq66hhbec5nb